person

Pierre G. P.

Country
France
Department
Cardiology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 26 partner sites.

Specializations

Cardiovascular disease and cardiac remodeling

The investigator concentrates on heart failure, septic shock with hypercontractility, and primary prevention of atherosclerotic events.

  • Heart failure
  • Septic shock with hypercontractility
  • Primary prevention of ASCVD
  • Coronary heart disease
  • Acute myocardial infarction

Research integrates beta‑blocker strategies and novel lipid‑lowering agents.

Oncology – gastrointestinal and hepatobiliary malignancies

Focus includes colorectal cancer, pancreatic adenocarcinoma, and biliary tract cancers.

  • Colorectal cancer
  • Pancreatic adenocarcinoma
  • Biliary tract cancer
  • Ampullary adenocarcinoma
  • Small bowel adenocarcinoma

Trials evaluate chemotherapy intensification and molecularly guided maintenance.

Gynecologic and breast oncology

Active interest in breast cancer, endometrial cancer, and ovarian cancer subtypes.

  • Hormone‑positive breast cancer
  • Triple‑negative breast cancer
  • p53abn endometrial cancer
  • High‑risk ovarian cancer
  • HER2‑negative disease

Therapeutic strategies involve endocrine combinations and DNA‑damage response inhibitors.

Hematology and immune‑mediated disorders

Investigations cover AL amyloidosis, chronic lymphocytic leukemia, and eosinophilic granulomatosis with polyangiitis.

  • AL amyloidosis
  • Chronic lymphocytic leukemia
  • Eosinophilic granulomatosis with polyangiitis
  • Polycythaemia vera
  • Diffuse large B‑cell lymphoma

Approaches include targeted agents and glucocorticoid‑sparing regimens.

Metabolic and renal‑cardiac intersection

The investigator addresses type 2 diabetes with concurrent cardiovascular disease and hypertension.

  • Dapagliflozin in post‑MI remodeling
  • Empagliflozin combination therapy
  • Hypertension management
  • Renal outcome optimization
  • Heart failure hospitalization reduction

Studies target cardiac remodeling and heart failure hospitalization reduction.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.